Portfolio map · VC firm · United States
Flagship Pioneering portfolio map
39 startups Flagship Pioneering has backed in rounds we track, since 2017, grouped by their main sector. Together they have raised $4.5B. The biggest sector is Biotech, with 26 companies.
39startups backed
4sectors
$4.5Braised between them
Biotechbiggest sector
Biotech
26
Denali Therapeutics
Laronde
Rubius Therapeutics
Repertoire Immune Medicines
Kaleido BioSciences
KSQ Therapeutics
Senda Biosciences
Cellarity
Visterra
Alltrna
Codiak Biosciences
Ring Therapeutics- CCodiak
Evelo Biosciences
Vesalius Therapeutics
ProFound Therapeutics
Cygnal
Etiome
Quotient Therapeutics
Metaphore Biotechnologies
Omega Therapeutics
Tarveda Therapeutics
Axcella
Torque
+2 more
Funding by segment
- Biotech$3.1B26
- Agtech$559M5
- AI$721M5
- Pharma$119M3
Where they are based
- United States37$4.3B
- United Kingdom1$50M
United States
United KingdomFounded
4Earlier
112
213
14
615
116
417
218
119
220
421
222
23
24
125
26
9 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M6
- $50M to $250M26
- $250M to $1B5
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
30 of 39 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States37
- United Kingdom1
Startups by country, 2 countries in all.
Segment by segment
Biotech
26 startups · $3.1B raised
- Denali TherapeuticsDenali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.United States$547M
- LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
- Rubius TherapeuticsRubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.United States$300M
- Repertoire Immune MedicinesRepertoire Immune Medicines is a clinical stage biotechnology company.-$189M
- Kaleido BioSciencesKaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.United States$161M
- KSQ TherapeuticsKSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.United States$156M
- Senda BiosciencesSenda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.United States$123M
- CellarityCellarity is a biotechnology therapeutics company based in Somerville, Massachusetts, founded in 2017 by Flagship Pioneering.United States$121M
Agtech
5 startups · $559M raised
- IAIndigo AgricultureUnited States$250M
InariInari is a seed design and biotechnology company developing seeds for a nature-positive food system.United States$150M
IndigoNestled at the corner of Trinity Place and Rector Street, in the Financial District, enjoy personalized, intimate service.United States$60M
Terrana BiosciencesTerrana's novel technology platform enables resilient agriculture for a rapidly changing world through RNA-based plant health solutions.United States$50M
Invaio SciencesInvaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.United States$50M
AI
5 startups · $721M raised
Lila SciencesLila Sciences is a biotechnology company based in Cambridge, Massachusetts, founded in 2023 through a merger of two projects from United States$551M
Expedition MedicinesExpedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.United States$50M
Mirai BioMirai Bio provides access to end-to-end development capabilities with innovation at every step.United States$50M
Empress TherapeuticsEmpress Therapeutics is a biotechnology company focused on small-molecule drug discovery.United States$50M
ExtuitiveExtuitive is an AI-first technology company based in Cambridge, Massachusetts, founded in 2025 by Flagship Pioneering.United States$20M
Pharma
3 startups · $119M raised
Ampersand BiomedicinesAmpersand Biomedicines is a biotechnology startup based in Boston, founded in 2021 by Flagship Pioneering.United States$65M
Foghorn TherapeuticsFoghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,United States$50M
Seres TherapeuticsSeres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.United States$3.6M
How this map is made. Every startup here has raised money in a round we track that names Flagship Pioneering as an investor, the first in 2017. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioFlagship Pioneering's Biotech portfolio25 startups · $3.1BCo-investorsWho invests with Flagship Pioneering15 co-investorsPortfolio mapTechstars portfolio map1,119 startups · $16BPortfolio mapAlumni Ventures portfolio map745 startups · $64BPortfolio mapAndreessen Horowitz portfolio map694 startups · $497BPortfolio mapSequoia Capital portfolio map651 startups · $677B
Raising from investors like Flagship Pioneering?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.